BridgeBio Oncology Therapeutics Inc (NAS:BBOT)
$ 9.33 +0.55 (+6.26%) Market Cap: 747.40 Mil Enterprise Value: 497.77 Mil PE Ratio: 0 PB Ratio: 2.01 GF Score: 12/100

BridgeBio Oncology Therapeutics Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2026 / 01:15AM GMT
Release Date Price: $11.51 (-9.16%)
Anupam Rama
JPMorgan Chase & Co - Analyst

All right. Welcome, everyone, to the 44th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by my squad, Priyanka Grover, Joyce Zhou and Rati Pinge.

Kicking off the conference, we have BridgeBio. And then presenting on behalf of the company, we have CEO, Neil Kumar. Neil?

Neil Kumar
BridgeBio Pharma Inc - Chief Executive Officer, Director

Well, thanks, everyone, for taking the time this morning. I'd like to thank Mike, Ben and the entire JPMorgan team for having us here again this year. This morning, I was reminded that BridgeBio turns 10 this year. And for a vast majority of those years, we've had the absolute privilege of being pajooled, challenged, and sometimes supported by the man to the left at me here, Anupam. So thank you for the partnership through the years, Anup.

Maybe I'll continue in that vein of thinking and thank all of the investors, both in the room and on the line for the support over the last

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot